\BOOKMARK [0][-]{section*.4}{Glossary}{}% 1
\BOOKMARK [0][-]{section*.6}{Acronyms}{}% 2
\BOOKMARK [0][-]{chapter*.7}{References}{}% 201
\BOOKMARK [0][-]{appendix.C}{Mutation Analysis in Breast Cancer}{}% 206
\BOOKMARK [1][-]{section.C.1}{Synthetic Lethal Genes and Pathways}{appendix.C}% 207
\BOOKMARK [1][-]{section.C.2}{Synthetic Lethal Expression Profiles}{appendix.C}% 208
\BOOKMARK [1][-]{section.C.3}{Comparison to Primary Screen}{appendix.C}% 209
\BOOKMARK [2][-]{subsection.C.3.1}{Resampling Analysis}{section.C.3}% 210
\BOOKMARK [1][-]{section.C.4}{Compare SLIPT genes}{appendix.C}% 211
\BOOKMARK [1][-]{section.C.5}{Metagene Analysis}{appendix.C}% 212
\BOOKMARK [1][-]{section.C.6}{Expression of Somatic Mutations}{appendix.C}% 213
\BOOKMARK [1][-]{section.C.7}{Metagene Expression Profiles}{appendix.C}% 214
\BOOKMARK [0][-]{appendix.D}{Intrinsic Subtyping}{}% 215
\BOOKMARK [0][-]{appendix.E}{Stomach Expression Analysis}{}% 216
\BOOKMARK [1][-]{section.E.1}{Synthetic Lethal Genes and Pathways}{appendix.E}% 217
\BOOKMARK [1][-]{section.E.2}{Synthetic Lethal Expression Profiles}{appendix.E}% 218
\BOOKMARK [1][-]{section.E.3}{Comparison to Primary Screen}{appendix.E}% 219
\BOOKMARK [2][-]{subsection.E.3.1}{Resampling Analysis}{section.E.3}% 220
\BOOKMARK [1][-]{section.E.4}{Metagene Analysis}{appendix.E}% 221
